The vaccine-specific CD8+ T cell response can provide long-term protection against HPV-induced skin cancer and HCC but is dependent on the induction and accumulation of CD8+ Trm cells by blocking CTLA-4 early after immunization (61). Here, CD8A is linked to skin cancer.